查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1775386

临床试验包装市场：预测（2025-2030）

Global Clinical Trials Packaging Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 142 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

临床试验包装市场预计将从 2025 年的 27.4 亿美元成长到 2030 年的 41.39 亿美元，复合年增长率为 8.60%。

全球临床试验包装市场分析报告全面分析了满足全球製药和生物技术公司需求的临床试验包装解决方案。本研究专为寻求深入了解该专业领域的市场动态、技术进步和竞争策略的行业专业人士量身定制。报告涵盖产品类型、材料类型、包装类型和区域格局，深入探讨市场趋势和机会，并特别关注竞争格局的最新发展。

市场概况和范围

全球临床试验包装市场分析报告探讨了包装在确保临床试验材料的完整性、安全性和合规性方面所发挥的关键作用。该市场涵盖各种包装解决方案，例如管瓶、泡壳、管、瓶、小袋、小袋、小袋和其他形式，并按材料（塑胶、玻璃、金属、纸/纸板等）和包装类型（一级、二级和三级）进行细分。分析涵盖北美、南美、欧洲、中东和非洲以及亚太地区等主要地区，深入洞察区域市场动态和各国特定趋势。报告还评估了市场驱动因素（例如临床试验活动的增加）和限制因素（例如严格的监管要求），以提供对成长潜力的客观观点。

竞争格局与分析

临床试验包装市场的竞争格局以策略创新和主要企业之间的联盟为特征。本节重点介绍主要市场参与企业的关键进展，以及他们为巩固市场地位和满足不断变化的行业需求所做的努力。以下是主要参与者取得的两项值得注意的进展：

  • Piramal Pharma Solutions：Piramal Pharma Solutions 近期透过对先进包装技术的策略性投资，扩展了其临床试验包装能力。 2024年，该公司推出了一系列整合物联网追踪系统的全新智慧包装解决方案。这些解决方案增强了临床试验材料的即时监控，确保运输过程中的温度控制和防篡改。这项发展契合了国际临床试验（尤其是生技药品和温敏型治疗产品）对安全合规包装日益增长的需求。
  • 赛默飞世尔科技：赛默飞世尔科技在临床试验永续包装方面取得了长足进步，推出了一系列面向2025年的环保包装解决方案，包括生物分解性包装袋和可回收二次包装，旨在满足环境法规要求的同时保持产品完整性。该倡议旨在响应监管机构和客户日益增长的压力，促使其在临床试验供应链中采用永续实践。透过将永续性融入其包装产品组合，赛默飞世尔科技不仅解决了环境问题，还吸引了那些重视环保实践的製药公司，从而帮助其提昇在临床试验包装市场的份额。

这些发展反映了竞争格局的广泛趋势，智慧和永续包装解决方案的创新正成为关键的差异化因素。本研究中的竞争分析还包括市场占有率评估、併购和联盟，从而全面展现了 Almac Group、Clinigen Clinical Supplies Management 和 PCI Services 等主要企业如何引领市场。竞争仪表板以可视化的方式呈现了这些动态，使行业专业人士能够评估他们的策略定位和市场影响力。

战略和技术见解

临床试验包装市场研究深入探讨了塑造该行业的先进技术，例如智慧包装的采用和包装流程的自动化。这些技术创新提高了效率，减少了错误，并确保遵守临床试验物流中至关重要的严格法规。该研究还包括波特五力分析，以评估竞争强度，以及产业价值链分析，重点在于从原材料供应商到包装服务供应商等关键相关人员的作用。研究还提供了策略建议，帮助企业抓住新机会，例如向亚太等高成长地区扩张以及投资永续包装解决方案。

本报告的主要优点

  • 深刻分析：获得涵盖主要地区和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他细分市场。
  • 竞争格局：了解全球主要企业所采用的策略策略，并了解正确策略带来的潜在市场渗透。
  • 市场驱动因素和未来趋势：探索动态因素和关键市场趋势以及它们将如何影响市场的未来发展。
  • 可行的建议：利用洞察力进行策略决策，在动态环境中开闢新的业务流和收益。
  • 适用范围广：对于新兴企业、研究机构、顾问公司、中小企业和大型企业来说，它都是实用且具有成本效益的。

它有什么用途？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、法律规范与影响、新产品开发、竞争影响

分析范围

  • 历史资料（2022-2024）和预测资料（2025-2030）
  • 成长机会、挑战、供应链前景、法规结构、顾客行为、趋势分析
  • 竞争对手定位、策略和市场占有率分析
  • 按部门和地区（国家）分類的收益成长和预测分析
  • 公司概况（策略、产品、财务资讯、主要趋势等）

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 研究范围
  • 市场区隔

第三章 商业景气

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策法规
  • 策略建议

第四章 技术展望

第五章全球临床试验包装市场（依产品类型）

  • 介绍
  • 管瓶
  • 泡壳
  • 管子
  • 瓶子
  • 小袋
  • 袋子和小袋
  • 其他的

6. 全球临床试验包装市场（依材料类型）

  • 介绍
  • 塑胶
  • 玻璃
  • 金属
  • 纸和纸板
  • 其他的

7. 全球临床试验包装市场（依包装类型）

  • 介绍
  • 初级包装
  • 二次包装
  • 三级包装

8. 全球临床试验包装市场（按地区）

  • 介绍
  • 北美洲
    • 依产品类型
    • 依材料类型
    • 按包装类型
    • 按国家
      • 美国
      • 加拿大
      • 墨西哥
  • 南美洲
    • 依产品类型
    • 依材料类型
    • 按包装类型
    • 按国家
      • 巴西
      • 阿根廷
      • 其他的
  • 欧洲
    • 依产品类型
    • 依材料类型
    • 按包装类型
    • 按国家
      • 英国
      • 德国
      • 法国
      • 西班牙
      • 其他的
  • 中东和非洲
    • 依产品类型
    • 依材料类型
    • 按包装类型
    • 按国家
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 其他的
  • 亚太地区
    • 依产品类型
    • 依材料类型
    • 按包装类型
    • 按国家
      • 中国
      • 日本
      • 印度
      • 韩国
      • 台湾
      • 其他的

第九章竞争格局及分析

  • 主要企业和策略分析
  • 市场占有率分析
  • 企业合併、协议、商业合作
  • 竞争仪錶板

第十章 公司简介

  • Piramal Pharma Solutions
  • Almac Group
  • Thermo Fisher Scientific Inc.
  • Clinigen Clinical Supplies Management
  • Xerimis
  • PCI Services
  • SGS SA（Quay Pharma）
  • Bilcare Ltd
  • Lonza
  • Mikart, LLC

第十一章 附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益
  • 分析方法
  • 简称
简介目录
Product Code: KSI061613487

The Global Clinical Trials Packaging Market is expected to grow from USD 2.740 billion in 2025 to USD 4.139 billion in 2030, at a CAGR of 8.60%.

The Global Clinical Trials Packaging Market study provides a comprehensive analysis of the packaging solutions tailored for clinical trials, addressing the needs of pharmaceutical and biotechnology companies worldwide. This study is designed for industry experts seeking in-depth insights into market dynamics, technological advancements, and competitive strategies shaping this specialized sector. Covering product types, material types, packaging types, and geographic regions, the study offers a detailed examination of market trends and opportunities, with a particular focus on recent developments in the competitive landscape.

Market Overview and Scope

The Global Clinical Trials Packaging Market study explores the critical role of packaging in ensuring the integrity, safety, and compliance of clinical trial materials. It defines the market as encompassing packaging solutions such as vials, blisters, tubes, bottles, sachets, bags, pouches, and other formats, segmented by material (plastic, glass, metal, paper & paperboard, and others) and packaging type (primary, secondary, and tertiary). The analysis spans key regions, including North America, South America, Europe, Middle East and Africa, and Asia Pacific, providing granular insights into regional market dynamics and country-specific trends. The study also evaluates market drivers, such as increasing clinical trial activities, and restraints, including stringent regulatory requirements, to offer a balanced perspective on growth potential.

Competitive Environment and Analysis

In the Global Clinical Trials Packaging Market, the competitive environment is marked by strategic innovations and collaborations among key players. This section highlights significant developments from major market participants, focusing on their efforts to strengthen market positions and address evolving industry demands. Below are two notable developments from key players:

  • Piramal Pharma Solutions: Piramal Pharma Solutions has recently expanded its clinical trial packaging capabilities through strategic investments in advanced packaging technologies. In 2024, the company introduced a new line of smart packaging solutions integrated with IoT-enabled tracking systems. These solutions enhance real-time monitoring of clinical trial materials, ensuring temperature control and tamper-evidence during transportation. This development aligns with the growing demand for secure and compliant packaging in global clinical trials, particularly for biologics and temperature-sensitive therapies. Piramal's focus on technology-driven packaging positions it as a leader in addressing regulatory and logistical challenges, strengthening its competitive edge in the market.
  • Thermo Fisher Scientific Inc.: Thermo Fisher Scientific has made significant strides in sustainable packaging for clinical trials, launching a range of eco-friendly packaging solutions in 2025. These include biodegradable pouches and recyclable secondary packaging designed to meet environmental regulations while maintaining product integrity. This initiative responds to increasing pressure from regulatory bodies and clients to adopt sustainable practices in clinical trial supply chains. By integrating sustainability into its packaging portfolio, Thermo Fisher not only addresses environmental concerns but also appeals to pharmaceutical companies prioritizing green initiatives, enhancing its market share in the Global Clinical Trials Packaging Market.

These developments reflect broader trends in the competitive landscape, where innovation in smart and sustainable packaging solutions is becoming a key differentiator. The study's competitive analysis also includes market share evaluations, mergers, acquisitions, and collaborations, providing a holistic view of how major players like Almac Group, Clinigen Clinical Supplies Management, and PCI Services are navigating the market. The competitive dashboard offers a visual representation of these dynamics, enabling industry experts to assess strategic positioning and market influence.

Strategic and Technological Insights

The Global Clinical Trials Packaging Market study delves into technological advancements shaping the industry, such as the adoption of smart packaging and automation in packaging processes. These innovations enhance efficiency, reduce errors, and ensure compliance with stringent regulations, which are critical in clinical trial logistics. The study also includes a Porter's Five Forces analysis to evaluate competitive intensity and an industry value chain analysis to highlight key stakeholders' roles, from raw material suppliers to packaging service providers. Strategic recommendations are provided to help companies capitalize on emerging opportunities, such as expanding into high-growth regions like Asia Pacific or investing in sustainable packaging solutions.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

By Product Type

  • Vials
  • Blisters
  • Tubes
  • Bottles
  • Sachets
  • Bags and Pouches
  • Others

By Material Type

  • Plastic
  • Glass
  • Metal
  • Paper & Paperboard
  • Others

By Packaging Type

  • Primary Packaging
  • Secondary Packaging
  • Tertiary Packaging

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL CLINICAL TRIALS PACKAGING MARKET BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. Vials
  • 5.3. Blisters
  • 5.4. Tubes
  • 5.5. Bottles
  • 5.6. Sachets
  • 5.7. Bags and Pouches
  • 5.8. Others

6. GLOBAL CLINICAL TRIALS PACKAGING MARKET BY MATERIAL TYPE

  • 6.1. Introduction
  • 6.2. Plastic
  • 6.3. Glass
  • 6.4. Metal
  • 6.5. Paper & Paperboard
  • 6.6. Others

7. GLOBAL CLINICAL TRIALS PACKAGING MARKET BY PACKAGING TYPE

  • 7.1. Introduction
  • 7.2. Primary Packaging
  • 7.3. Secondary Packaging
  • 7.4. Tertiary Packaging

8. GLOBAL CLINICAL TRIALS PACKAGING MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Product Type
    • 8.2.2. By Material Type
    • 8.2.3. By Packaging Type
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Product Type
    • 8.3.2. By Material Type
    • 8.3.3. By Packaging Type
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Product Type
    • 8.4.2. By Material Type
    • 8.4.3. By Packaging Type
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Spain
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Product Type
    • 8.5.2. By Material Type
    • 8.5.3. By Packaging Type
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Product Type
    • 8.6.2. By Material Type
    • 8.6.3. By Packaging Type
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Taiwan
      • 8.6.4.6. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Piramal Pharma Solutions
  • 10.2. Almac Group
  • 10.3. Thermo Fisher Scientific Inc.
  • 10.4. Clinigen Clinical Supplies Management
  • 10.5. Xerimis
  • 10.6. PCI Services
  • 10.7. SGS SA (Quay Pharma)
  • 10.8. Bilcare Ltd
  • 10.9. Lonza
  • 10.10. Mikart, LLC

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key benefits for the stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations